Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction
- PMID: 3980801
- DOI: 10.1016/s0190-9622(85)70005-9
Methoxsalen and ultraviolet A radiation in treatment of chronic cutaneous graft-versus-host reaction
Abstract
Chronic cutaneous graft-versus-host reaction following bone marrow transplantation has been difficult to manage in some patients because of poor response to immunosuppressive agents or because of toxicity to these drugs. We recently used methoxsalen and ultraviolet A therapy and found it to be successful in controlling chronic cutaneous lichenoid graft-versus-host reaction in a bone marrow transplant patient. Although there was an initial flare of an eruption resembling acute cutaneous graft-versus-host reaction, both this acute eruption and the lichenoid lesions subsided and cleared with continued treatment. The skin lesions recurred when treatment was discontinued but responded promptly when it was initiated for the second time. Other than mild phototoxicity, there were no other significant side effects.
Similar articles
-
Photochemotherapy improves chronic cutaneous graft-versus-host disease.J Am Acad Dermatol. 1990 Aug;23(2 Pt 1):220-8. doi: 10.1016/0190-9622(90)70202-s. J Am Acad Dermatol. 1990. PMID: 2212117
-
Lichen planus-like eruption following autologous bone marrow transplantation for chronic myeloid leukaemia.Australas J Dermatol. 2001 Aug;42(3):188-91. doi: 10.1046/j.1440-0960.2001.00512.x. Australas J Dermatol. 2001. PMID: 11488713
-
8-Methoxypsoralen and ultraviolet A therapy for cutaneous manifestations of graft-versus-host disease.Transplantation. 1990 Nov;50(5):807-11. doi: 10.1097/00007890-199011000-00013. Transplantation. 1990. PMID: 2238056
-
[Alloimmunity and autoimmunity. I. Skin aspects].Ann Pathol. 1989;9(3):170-4. Ann Pathol. 1989. PMID: 2667532 Review. French.
-
Dermatologic treatment of cutaneous graft versus host disease.Am J Clin Dermatol. 2004;5(6):403-16. doi: 10.2165/00128071-200405060-00005. Am J Clin Dermatol. 2004. PMID: 15663337 Review.
Cited by
-
Management of graft-versus-host disease in paediatric bone marrow transplant recipients.Paediatr Drugs. 2000 Jan-Feb;2(1):29-55. doi: 10.2165/00148581-200002010-00004. Paediatr Drugs. 2000. PMID: 10937457 Review.
-
UVA/UVA1 phototherapy and PUVA photochemotherapy in connective tissue diseases and related disorders: a research based review.BMC Dermatol. 2004 Sep 20;4(1):11. doi: 10.1186/1471-5945-4-11. BMC Dermatol. 2004. PMID: 15380024 Free PMC article. Review.
-
Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.Int J Hematol. 2014 Apr;99(4):471-6. doi: 10.1007/s12185-014-1530-1. Epub 2014 Feb 21. Int J Hematol. 2014. PMID: 24557710
-
Narrowband ultraviolet B phototherapy for the treatment of steroid-refractory and steroid-dependent acute graft-versus-host disease of the skin.J Am Acad Dermatol. 2011 Oct;65(4):733-738. doi: 10.1016/j.jaad.2010.08.006. Epub 2011 May 25. J Am Acad Dermatol. 2011. PMID: 21616558 Free PMC article.
-
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report.Biol Blood Marrow Transplant. 2015 Jul;21(7):1167-87. doi: 10.1016/j.bbmt.2015.03.024. Epub 2015 Mar 31. Biol Blood Marrow Transplant. 2015. PMID: 25838185 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources